TABLE 2.
Characteristics | SDSG change | CV change | ||||||
---|---|---|---|---|---|---|---|---|
Unadjusted | Adjusted for age and sex | Unadjusted | Adjusted for age and sex | |||||
r | p | r | p | r | p | r | p | |
Male sex | −0.048 | .821 | – | – | 0.012 | .955 | – | – |
Age | −0.272 | .189 | – | – | −0.227 | .276 | – | – |
BMI | −0.190 | .364 | −0.269 | .226 | −0.260 | .209 | −0.371 | .090 |
Fat mass | −0.112 | .593 | −0.126 | .576 | −0.215 | .302 | −0.255 | .253 |
Fat percentage | −0.172 | .410 | −0.122 | .589 | −0.289 | .161 | −0.277 | .213 |
HbA1c | −0.252 | .224 | −0.215 | .336 | −0.070 | .739 | −0.011 | .960 |
FPG | −0.308 | .134 | −0.299 | .177 | −0.146 | .487 | −0.141 | .530 |
HOMA‐IR a | −0.331 | .106 | −0.418 | .053 | −0.255 | .218 | −0.404 | .062 |
HOMA‐β a | −0.077 | .715 | −0.137 | .543 | −0.146 | .486 | −0.264 | .235 |
Total cholesterol | −0.119 | .571 | −0.208 | .353 | 0.029 | .890 | −0.079 | .725 |
Triglycerides a | 0.143 | .505 | 0.066 | .771 | 0.316 | .132 | 0.284 | .200 |
HDL‐C a | −0.238 | .252 | −0.145 | .520 | −0.303 | .141 | −0.254 | .253 |
LDL‐C a | −0.093 | .659 | −0.067 | .766 | 0.014 | .949 | 0.044 | .846 |
ASFA a | 0.002 | .992 | 0.087 | .701 | −0.108 | .606 | −0.049 | .828 |
VFA a | −0.526 | .007 | −0.751 | < .001 | −0.458 | .021 | −0.774 | < .001 |
HSFA a | 0.073 | .729 | 0.105 | .641 | −0.072 | .732 | −0.088 | .696 |
HMA a | −0.075 | .720 | −0.330 | .133 | −0.016 | .938 | −0.290 | .190 |
LSFA a | 0.018 | .931 | −0.041 | .855 | −0.102 | .629 | −0.184 | .412 |
LMA a | −0.030 | .886 | −0.231 | .300 | 0.002 | .991 | −0.239 | .283 |
U‐TSFA a | −0.007 | .974 | 0.027 | .907 | −0.154 | .462 | −0.127 | .572 |
U‐TMA a | −0.009 | .966 | −0.289 | .191 | 0.034 | .871 | −0.259 | .245 |
M‐TSFA a | 0.099 | .639 | 0.097 | .668 | −0.013 | .950 | −0.028 | .903 |
M‐TMA a | 0.053 | .802 | −0.175 | .435 | 0.118 | .574 | −0.125 | .579 |
Liver fat a | −0.048 | .818 | −0.110 | .626 | 0.118 | .575 | 0.032 | .887 |
Abbreviations: ASFA, abdominal subcutaneous fat area; BMI, body mass index; CV, coefficient of variation; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HDL‐C, high density lipoprotein cholesterol; HOMA, homeostasis model assessment; HMA, hip muscle area; HSFA, hip subcutaneous fat area; LDL‐C, low density lipoprotein cholesterol; LMA, lower leg muscle area; LSFA, lower leg subcutaneous fat area; M‐TMA, mid‐thigh muscle area; M‐TSFA, mid‐thigh subcutaneous fat area; SDSG, SD of sensor glucose; U‐TSFA, upper thigh subcutaneous fat area; U‐TMA, upper thigh muscle area; VFA, visceral fat area.
Loge‐transformed before analysis.